The novel treatment of the medication represents a exciting breakthrough in the care of the condition. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide318372.ziblogs.com/42378306/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment